Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast February 15, 2024 About 1 in 5 colorectal patients are now under the…
Originally broadcast February 27, 2025. How reliable is the current research into the cause of…
Dr. Louis Sullivan walked the halls of Congress and testified before committees when he was…
Originally broadcast February 13, 2025 $4.95 — that’s the record high price of a dozen…
Originally broadcast February 6, 2025 Artificial intelligence is revolutionizing health care—but how do we ensure…
Originally broadcast January 30, 2025. Noted healthcare leader Dr. Sachin Jain has been publicly releasing…